The Health Technology Assessment Association and the St. Petersburg chapter of the International Society for Pharmacoeconomics and Outcomes Research – ISPOR, would like to invite you to attend the conference titled “RWD/RWE: Critical Tool in Healthcare Decisions,” that will be held in September 24, 2020.
The Conference will demonstrate the significance of collecting real-world data (RWD) and real-world evidence (RWE), and tackle possible amendments to the current legislation concerning the use of RWD/RWE in the Russian healthcare system.
RWD is a present-day concern of the healthcare system that for the past several years has been getting greater attention in the USA and most of the European countries.
Currently RWD/RWE is a matter of great importance, as it allows to address routine healthcare problems from efficacy, safety and accessibility perspective. As a result, RWD/RWE influence the healthcare policies and protect the public welfare.
The access to the Conference will be available to health professionals through online streams.
The Conference welcomes leading experts in clinical studies, health technology assessment, pharmacovigilance, pharmacoeconomics, applicable healthcare, Big Data, representatives of patient and non-governmental organizations, pharmaceutical industry, the Russian Ministry of Health, and federal officeholders.
More details about the event are available following the link.
The Conference is hosted by Aston Health.
For registration please contact Alexander Ivanov, A.Ivanov@aston-health.com